Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

MHRA consult on OTC decongestants

The Medicines and Healthcare products Regulatory Agency has opened a public consultation on the proposal to restrict access to the availability of pseudoephedrine and ephedrine.

This consultation is in response to the Annual Report of the International Narcotics Control Board that identified that these medicines are used in the illegal manufacture of methylamphetamine, a Class A drug more commonly known as crystal meth.

Action: All healthcare professionals should be aware of the consultation and of the potential to illegally use pseudoephedrine and ephedrine in the manufacture of a Class A drug. Supplies of both drugs should be restricted to ensure inappropriate use is kept to a minimum.

Share 'MHRA consult on OTC decongestants' on Email Share 'MHRA consult on OTC decongestants' on Delicious Share 'MHRA consult on OTC decongestants' on Digg Share 'MHRA consult on OTC decongestants' on Facebook Share 'MHRA consult on OTC decongestants' on Google+ Share 'MHRA consult on OTC decongestants' on reddit Share 'MHRA consult on OTC decongestants' on StumbleUpon Share 'MHRA consult on OTC decongestants' on Twitter

atomic-wealth

No Comments to “MHRA consult on OTC decongestants”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,668 spam comments.

atomic-wealth
fond-illness
summer